Health
SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model – EurekAlert
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist…
IMAGE: Hollings Cancer Center researcher Nancy Klauber-DeMore, M.D., is leading the first breakthrough in pediatric osteosarcoma treatment in decades.
view more
Credit: MUSC Hollings Cancer Center/Marquel Coaxum
In a cancer that has not seen new targeted…
Continue Reading
-
Business21 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business20 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News17 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business17 hours ago1 ASX dividend stock down 43% I’d buy right now